Soligenix, Inc. (SNGX)
NASDAQ: SNGX · Real-Time Price · USD
0.3650
+0.0005 (0.14%)
At close: Oct 23, 2026, 4:00 PM EDT
0.3616
-0.0034 (-0.93%)
After-hours: Oct 23, 2026, 7:22 PM EDT
Soligenix Market Cap
Soligenix has a market cap or net worth of $7.94 million as of October 23, 2026. It is the 42,684th most valuable company in the world and the 5,721st biggest in the United States. Its market cap has increased by 15.14% in one year.
Market Cap
7.94M
Enterprise Value
-1.56M
1-Year Change
15.14%
Global Rank
Country Rank
#5,721 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Soligenix's market cap has decreased from $24.80M to $7.94M, a decrease of -67.97%. That is a compound annual growth rate of -4.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 7.90M | -41.48% |
| Dec 31, 2025 | 13.50M | 98.53% |
| Dec 31, 2024 | 6.80M | -13.92% |
| Dec 29, 2023 | 7.90M | -59.49% |
| Dec 30, 2022 | 19.50M | -31.10% |
| Dec 31, 2021 | 28.30M | -25.92% |
| Dec 31, 2020 | 38.20M | 27.76% |
| Dec 31, 2019 | 29.90M | 96.71% |
| Dec 31, 2018 | 15.20M | -21.65% |
| Dec 29, 2017 | 19.40M | 128.24% |
| Dec 30, 2016 | 8.50M | -72.40% |
| Dec 31, 2015 | 30.80M | 42.59% |
| Dec 31, 2014 | 21.60M | -37.39% |
| Dec 31, 2013 | 34.50M | 414.93% |
| Dec 31, 2012 | 6.70M | 1.52% |
| Dec 30, 2011 | 6.60M | -83.90% |
| Dec 31, 2010 | 41.00M | -11.64% |
| Dec 31, 2009 | 46.40M | 660.66% |
| Dec 31, 2008 | 6.10M | -62.11% |
| Dec 31, 2007 | 16.10M | -2.42% |
| Dec 29, 2006 | 16.50M | 20.44% |
| Dec 30, 2005 | 13.70M | -49.07% |
| Dec 31, 2004 | 26.90M | -0.37% |
| Dec 31, 2003 | 27.00M | 167.33% |
| Dec 31, 2002 | 10.10M | -22.90% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuron | 9.10M |
| MetaVia | 9.09M |
| Theriva Biologics | 8.99M |
| Lisata Therapeutics | 8.97M |
| Tempest Therapeutics | 8.45M |
| CalciMedica | 8.40M |
| Lantern Pharma | 8.12M |
| Vistagen Therapeutics | 7.97M |